Key result
Vasodilators cause unequal changes in the systemic distribution of blood flow to each organ, with differing effects observed between normal circulation and experimentally created heart failure.
Why the study?
How do vasodilators affect the systemic distribution of cardiac output in experimentally created heart failure?
How do vasodilators affect the systemic distribution of cardiac output in experimentally created heart failure?
This report reviews the differential effects of vasodilators on regional blood flow distribution in normal versus heart failure states.
For the last 20 years, vasodilator drugs have been used for the therapy of congestive heart failure. During this period, there has been increasing interest in the treatment of congestive heart failure. Vasodilators are divided into one which reduces preload, another which reduces after-load and the last which has both effects. Changes in cardiac output causes changes in distribution of cardiac output to each organ. Therefore, after vasodilators injection, changes in systemic distribution of blood flow should not be equal in each organ. In this report, changes in systemic distribution of cardiac output after vasodilator injection are discussed. Systemic distribution of blood flow in normal circulation differs from that in abnormal circulation. In this report, effects of vasodilators on systemic distribution of cardiac output in the state of experimentally created heart failure are discussed.
No takes yet. Share an insight, caveat, or question.
Senoo et al. (1984) conducted a review in Congestive heart failure. Vasodilators was evaluated on Systemic distribution of cardiac output. Vasodilators cause unequal changes in the systemic distribution of blood flow to each organ, with differing effects observed between normal circulation and experimentally created heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: